Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Leukocyte transendothelial migration (mmu04670)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
2900073G
15Rik
KLA  ATP  ATP+KLA
 NM_026064 RIKEN cDNA 2900073G15 gene (2900073G15Rik), mRNA [NM_026064] KLA 1.50 1.46 1.64 1.51 1.69 1.72 1.15
ATP 1.05 1.10 1.24 1.39 1.23 1.13 1.03
KLA/ATP 1.50 1.60 1.64 1.71 1.36 1.21 1.11
4930468A
15Rik
KLA  ATP  ATP+KLA
 AK015525 adult male testis cDNA, RIKEN full-length enriched library, clone:4930468A15 product:hypothetical protein, full insert sequence [AK015525] KLA .97 1.00 1.03 .98 1.02 1.01 1.02
ATP 1.03 .97 1.05 1.02 .99 .98 .98
KLA/ATP 1.01 1.00 .97 1.01 .95 .98 .96
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
Actn1
KLA  ATP  ATP+KLA
 NM_134156 actinin, alpha 1 (Actn1), mRNA [NM_134156] KLA 1.33 1.42 1.46 1.16 1.18 .69 .54
ATP 1.06 1.13 .67 1.15 .95 .99 1.46
KLA/ATP 1.66 1.64 .81 1.55 .82 .78 .76
Actn2
KLA  ATP  ATP+KLA
 NM_033268 actinin alpha 2 (Actn2), mRNA [NM_033268] KLA 1.03 .94 1.02 1.05 1.02 1.06 1.11
ATP 1.04 .98 1.07 .99 1.10 1.03 1.02
KLA/ATP 1.06 1.03 .99 1.08 1.01 1.05 .98
Actn3
KLA  ATP  ATP+KLA
 NM_013456 actinin alpha 3 (Actn3), mRNA [NM_013456] KLA .97 .98 .98 .94 1.03 .96 1.07
ATP .95 .95 1.02 .98 .94 .95 1.01
KLA/ATP 1.05 1.03 .94 1.03 1.03 1.00 .95
Actn4
KLA  ATP  ATP+KLA
 NM_021895 actinin alpha 4 (Actn4), mRNA [NM_021895] KLA .78 .77 .75 .74 .58 .51 .65
ATP 1.03 1.03 1.21 1.14 1.50 1.30 1.09
KLA/ATP .78 .85 .96 .84 1.09 1.12 .97
AK050363
KLA  ATP  ATP+KLA
 AK050363 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730040N22 product:unclassifiable, full insert sequence. [AK050363] KLA 1.00 .98 1.02 1.02 1.02 .92 .96
ATP .98 1.03 .93 .98 .96 1.02 .99
KLA/ATP 1.03 .96 .96 .95 1.02 .93 1.04
Arhgap5
KLA  ATP  ATP+KLA
 AK039081 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230093J24 product:unclassifiable, full insert sequence. [AK039081] KLA .95 .99 .86 .90 .95 .92 .87
ATP 1.05 1.06 1.03 .86 .93 .96 .96
KLA/ATP .90 .90 .92 .83 .92 .83 .86
Arhgap5
KLA  ATP  ATP+KLA
 NM_009706 Rho GTPase activating protein 5 (Arhgap5), mRNA [NM_009706] KLA .54 .52 .50 .51 .38 .37 .75
ATP 1.04 .78 .87 .64 1.25 1.16 1.29
KLA/ATP .49 .47 .51 .45 .81 .67 .92
Bcar1
KLA  ATP  ATP+KLA
 NM_009954 breast cancer anti-estrogen resistance 1 (Bcar1), mRNA [NM_009954] KLA .88 .87 .82 .88 1.06 1.12 1.70
ATP 1.04 1.05 1.00 1.27 1.34 1.62 1.34
KLA/ATP .95 .87 .87 .95 1.02 1.17 2.10
BG242006
KLA  ATP  ATP+KLA
 BG242006 gb|602354740F1 NCI_CGAP_Mam1 Mus musculus cDNA clone IMAGE:4483064 5. [BG242006] KLA 2.25 2.23 2.26 2.70 2.56 2.67 1.45
ATP .92 .87 1.11 .97 .99 .97 .72
KLA/ATP 1.91 2.04 2.51 2.08 1.99 1.15 .67
Cd99
KLA  ATP  ATP+KLA
 NM_025584 CD99 antigen (Cd99), mRNA [NM_025584] KLA .96 1.05 1.05 .95 .95 .83 .86
ATP 1.02 1.16 .98 1.46 1.14 1.02 .88
KLA/ATP 1.10 1.10 .88 1.39 .95 1.00 1.11
Cdc42
KLA  ATP  ATP+KLA
 NM_009861 cell division cycle 42 homolog (S. cerevisiae) (Cdc42), mRNA [NM_009861] KLA 1.04 1.01 1.02 1.04 1.12 1.21 1.12
ATP 1.07 1.10 1.04 1.06 1.02 .95 1.14
KLA/ATP .94 1.04 1.01 .97 .95 1.02 1.25
Cdh5
KLA  ATP  ATP+KLA
 NM_009868 cadherin 5 (Cdh5), mRNA [NM_009868] KLA 1.20 1.23 1.30 1.31 1.53 1.65 1.24
ATP .99 1.00 1.08 .96 .96 1.19 1.78
KLA/ATP 1.19 1.16 1.13 1.19 1.14 1.54 2.15
Cldn1
KLA  ATP  ATP+KLA
 NM_016674 claudin 1 (Cldn1), mRNA [NM_016674] KLA .97 1.02 1.02 1.05 1.05 .99 1.07
ATP 1.02 .94 1.03 1.08 1.05 .98 1.02
KLA/ATP 1.03 1.02 1.00 1.00 1.17 1.01 1.03
Cldn10
KLA  ATP  ATP+KLA
 NM_021386 claudin 10 (Cldn10), transcript variant 2, mRNA [NM_021386] KLA 1.06 1.05 1.04 1.12 1.08 1.05 1.04
ATP 1.07 .97 .98 1.06 1.00 1.01 .97
KLA/ATP 1.01 1.06 .86 .98 1.03 1.04 1.09
Cldn11
KLA  ATP  ATP+KLA
 NM_008770 claudin 11 (Cldn11), mRNA [NM_008770] KLA 1.05 1.10 1.04 .99 .97 .99 .97
ATP 1.03 1.01 1.08 3.05 1.24 1.11 1.07
KLA/ATP 1.02 .96 1.42 2.53 1.09 1.02 1.03
Cldn13
KLA  ATP  ATP+KLA
 NM_020504 claudin 13 (Cldn13), mRNA [NM_020504] KLA 1.02 1.00 1.02 .97 1.01 .98 .99
ATP .92 .96 1.05 .96 1.02 1.04 1.04
KLA/ATP .93 .94 1.10 1.06 1.00 .93 1.03
Cldn14
KLA  ATP  ATP+KLA
 NM_019500 claudin 14 (Cldn14), mRNA [NM_019500] KLA 1.03 1.12 1.14 1.08 1.09 1.16 1.08
ATP 1.03 .99 1.12 1.04 1.07 1.10 1.06
KLA/ATP 1.07 1.14 1.21 1.12 1.07 1.10 1.08
Cldn15
KLA  ATP  ATP+KLA
 NM_021719 claudin 15 (Cldn15), mRNA [NM_021719] KLA 1.01 1.07 1.04 1.09 1.06 1.11 .98
ATP 1.17 1.26 1.27 1.08 1.24 1.11 1.05
KLA/ATP 1.25 1.31 1.19 1.22 1.70 1.26 1.03
Cldn16
KLA  ATP  ATP+KLA
 NM_053241 claudin 16 (Cldn16), mRNA [NM_053241] KLA 1.08 .98 1.02 1.00 1.06 1.05 1.00
ATP 1.01 1.05 1.01 1.12 1.05 .98 .99
KLA/ATP .98 .95 1.04 1.05 1.02 1.15 1.01
Cldn17
KLA  ATP  ATP+KLA
 NM_181490 claudin 17 (Cldn17), mRNA [NM_181490] KLA .99 1.05 1.01 1.00 .97 .99 1.01
ATP .95 .98 1.06 1.05 .97 1.00 1.00
KLA/ATP 1.04 1.00 .95 1.05 .96 1.02 1.11
Cldn18
KLA  ATP  ATP+KLA
 NM_019815 claudin 18 (Cldn18), mRNA [NM_019815] KLA .99 1.06 .99 .99 1.03 1.13 1.11
ATP .96 1.00 1.10 .98 .95 .98 1.07
KLA/ATP 1.07 .95 1.05 1.07 1.11 1.06 1.02
Cldn19
KLA  ATP  ATP+KLA
 NM_001038590 claudin 19 (Cldn19), transcript variant 1, mRNA [NM_001038590] KLA 1.06 .92 1.01 1.01 1.03 .96 1.00
ATP 1.00 .97 1.05 .93 .95 .91 1.01
KLA/ATP .93 .99 .96 .93 .91 .92 .93
Cldn19
KLA  ATP  ATP+KLA
 NM_153105 claudin 19 (Cldn19), transcript variant 2, mRNA [NM_153105] KLA .97 1.01 1.02 1.05 1.06 .96 1.09
ATP 1.04 .98 1.08 1.02 .98 1.00 .96
KLA/ATP 1.02 1.03 1.03 1.02 1.00 1.02 1.03
Cldn2
KLA  ATP  ATP+KLA
 NM_016675 claudin 2 (Cldn2), mRNA [NM_016675] KLA .98 .93 1.02 1.04 1.00 1.03 1.01
ATP 1.01 1.01 1.00 1.06 1.01 .99 1.08
KLA/ATP 1.07 1.01 .72 1.04 1.04 1.04 1.00
Cldn22
KLA  ATP  ATP+KLA
 NM_029383 claudin 22 (Cldn22), mRNA [NM_029383] KLA .99 .99 .99 .99 .99 .98 .96
ATP 1.01 .95 .99 .98 1.06 .92 .98
KLA/ATP 1.02 1.07 .96 1.00 1.02 1.04 .99
Cldn23
KLA  ATP  ATP+KLA
 NM_027998 claudin 23 (Cldn23), mRNA [NM_027998] KLA 1.33 1.38 1.29 1.23 1.13 1.13 1.20
ATP .99 1.04 1.11 1.41 1.44 1.23 1.14
KLA/ATP 1.42 1.34 1.29 1.33 1.30 1.23 1.73
Cldn3
KLA  ATP  ATP+KLA
 NM_009902 claudin 3 (Cldn3), mRNA [NM_009902] KLA 1.04 1.02 1.06 1.09 1.08 1.13 1.09
ATP 1.02 1.02 1.06 1.03 1.01 1.00 1.01
KLA/ATP 1.07 1.05 1.19 1.10 1.07 1.13 1.15
Cldn4
KLA  ATP  ATP+KLA
 NM_009903 claudin 4 (Cldn4), mRNA [NM_009903] KLA 1.05 .99 .94 1.02 1.05 1.05 .98
ATP 1.01 1.04 1.01 .95 .96 1.09 1.09
KLA/ATP .98 1.11 1.08 1.05 .86 .95 1.07
Cldn5
KLA  ATP  ATP+KLA
 NM_013805 claudin 5 (Cldn5), mRNA [NM_013805] KLA 1.08 1.08 1.23 1.13 1.16 1.18 1.18
ATP 1.01 1.02 1.03 1.03 1.05 1.00 1.06
KLA/ATP 1.14 1.18 1.13 1.09 1.05 1.15 1.16
Cldn6
KLA  ATP  ATP+KLA
 NM_018777 claudin 6 (Cldn6), mRNA [NM_018777] KLA 1.06 1.04 .98 1.01 1.03 .99 .91
ATP .98 1.01 .94 .99 .95 1.14 1.07
KLA/ATP 1.02 .96 1.08 1.04 1.01 .95 1.05
Cldn7
KLA  ATP  ATP+KLA
 NM_016887 claudin 7 (Cldn7), mRNA [NM_016887] KLA 1.21 1.23 1.33 1.38 1.44 1.26 1.01
ATP 1.01 1.01 1.07 1.01 1.04 1.04 1.03
KLA/ATP 1.22 1.28 1.24 2.23 1.42 1.17 1.07
Cldn8
KLA  ATP  ATP+KLA
 NM_018778 claudin 8 (Cldn8), mRNA [NM_018778] KLA .98 .86 1.00 .98 1.02 1.06 .97
ATP .93 .99 1.01 1.00 1.05 1.01 1.03
KLA/ATP .98 1.08 .96 1.00 1.02 .98 1.00
Cldn9
KLA  ATP  ATP+KLA
 NM_020293 claudin 9 (Cldn9), mRNA [NM_020293] KLA 1.29 1.24 1.37 1.34 1.32 1.37 1.55
ATP .92 .90 1.30 1.47 1.43 1.32 1.12
KLA/ATP 1.16 1.26 2.03 1.63 1.89 1.39 1.30
Ctnna1
KLA  ATP  ATP+KLA
 AK008121 adult male small intestine cDNA, RIKEN full-length enriched library, clone:2010005H04 product:unclassifiable, full insert sequence. [AK008121] KLA .82 .76 .72 .81 .94 .74 .80
ATP 1.08 1.01 .51 .57 2.45 1.25 .95
KLA/ATP .91 .82 .76 .58 1.58 1.01 .92
Ctnna1
KLA  ATP  ATP+KLA
 NM_009818 catenin (cadherin associated protein), alpha 1 (Ctnna1), mRNA [NM_009818] KLA .97 .91 1.06 .84 .75 .52 .56
ATP 1.09 1.14 1.00 .86 .80 .98 .83
KLA/ATP 1.02 1.07 .90 .80 .66 .59 .57
Ctnna2
KLA  ATP  ATP+KLA
 AK035033 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430076K22 product:hypothetical Vinculin and alpha-catenin containing protein, full insert sequence [AK035033] KLA 1.05 1.11 1.12 1.05 1.02 1.04 1.19
ATP .99 .97 1.00 1.05 1.02 1.05 1.03
KLA/ATP 1.11 1.06 1.01 1.12 1.06 1.02 1.03
Ctnna3
KLA  ATP  ATP+KLA
 AK029664 adult male testis cDNA, RIKEN full-length enriched library, clone:4930438F12 product:unclassifiable, full insert sequence. [AK029664] KLA 1.03 1.06 .99 1.05 .95 1.01 1.04
ATP 1.03 1.05 1.02 1.04 .99 1.03 1.05
KLA/ATP 1.01 1.00 .99 1.01 1.00 .98 1.05
Ctnna3
KLA  ATP  ATP+KLA
 NM_177612 catenin (cadherin associated protein), alpha 3 (Ctnna3), mRNA [NM_177612] KLA 1.01 1.06 .98 1.04 1.03 1.04 1.07
ATP .96 1.02 .94 1.11 1.02 1.09 .91
KLA/ATP 1.01 .94 .94 1.10 1.10 1.04 1.04
Ctnnb1
KLA  ATP  ATP+KLA
 AK020013 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830416C23 product:catenin beta, full insert sequence. [AK020013] KLA 1.06 1.15 1.00 1.06 1.27 1.14 1.03
ATP .85 .57 1.74 3.36 4.13 2.19 1.55
KLA/ATP 1.12 .87 2.47 3.61 3.79 2.21 2.06
Ctnnb1
KLA  ATP  ATP+KLA
 NM_007614 catenin (cadherin associated protein), beta 1 (Ctnnb1), mRNA [NM_007614] KLA 1.02 1.07 1.13 1.03 1.04 .93 .96
ATP 1.12 1.14 .75 .77 .73 .72 1.52
KLA/ATP 1.18 1.17 .77 .85 .60 .59 1.35
Ctnnd1
KLA  ATP  ATP+KLA
 NM_007615 catenin (cadherin associated protein), delta 1 (Ctnnd1), transcript variant 1, mRNA [NM_007615] KLA 1.94 1.92 2.21 1.62 1.28 1.01 1.10
ATP 1.15 .87 .49 .55 .71 1.90 2.20
KLA/ATP 2.22 1.83 .80 .75 .58 1.20 2.61
Cxcl12
KLA  ATP  ATP+KLA
 NM_001012477 chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript variant 3, mRNA [NM_001012477] KLA .91 .91 .92 .92 .91 1.00 .85
ATP 1.00 .99 1.02 .99 .91 .93 .88
KLA/ATP .89 .91 .97 .97 .94 .93 .82
Cxcl12
KLA  ATP  ATP+KLA
 NM_021704 chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript variant 1, mRNA [NM_021704] KLA 1.01 .96 1.04 1.04 .94 .98 .94
ATP 1.01 .92 .98 1.04 1.02 .94 .98
KLA/ATP 1.02 .98 1.07 .95 1.02 .98 .99
Cxcr4
KLA  ATP  ATP+KLA
 NM_009911 chemokine (C-X-C motif) receptor 4 (Cxcr4), mRNA [NM_009911] KLA .30 .34 .26 .31 .25 .29 .42
ATP 1.27 2.70 6.37 11.61 7.04 1.14 4.92
KLA/ATP .28 .34 .56 2.60 3.47 1.23 1.28
Cyba
KLA  ATP  ATP+KLA
 NM_007806 cytochrome b-245, alpha polypeptide (Cyba), mRNA [NM_007806] KLA 1.02 1.05 1.06 .91 1.03 1.04 1.68
ATP 1.05 1.11 1.00 1.36 1.10 .95 1.21
KLA/ATP 1.03 1.11 .93 1.31 1.01 1.03 1.47
Cybb
KLA  ATP  ATP+KLA
 NM_007807 cytochrome b-245, beta polypeptide (Cybb), mRNA [NM_007807] KLA 5.43 5.43 5.59 5.19 5.71 5.00 5.08
ATP 1.08 1.18 1.19 1.64 1.68 2.73 1.82
KLA/ATP 5.34 5.62 4.98 6.75 3.74 3.36 3.96
Esam1
KLA  ATP  ATP+KLA
 NM_027102 endothelial cell-specific adhesion molecule (Esam1), mRNA [NM_027102] KLA 1.00 1.03 1.04 1.05 1.02 1.11 1.12
ATP 1.03 1.00 1.02 1.13 1.21 1.36 1.14
KLA/ATP 1.05 1.00 1.04 1.16 1.30 1.53 1.29
Ezr
KLA  ATP  ATP+KLA
 NM_009510 ezrin (Ezr), mRNA [NM_009510] KLA 2.87 2.71 2.24 2.32 2.31 1.91 1.08
ATP 1.04 1.05 1.11 1.87 4.65 5.96 1.64
KLA/ATP 2.94 2.63 2.59 3.03 2.98 3.38 4.32
F11r
KLA  ATP  ATP+KLA
 NM_172647 F11 receptor (F11r), mRNA [NM_172647] KLA 7.81 8.47 6.77 8.24 6.97 3.97 1.27
ATP .91 .90 1.38 1.45 3.39 8.01 2.55
KLA/ATP 6.57 8.31 8.96 8.00 8.69 7.39 14.52
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Grlf1
KLA  ATP  ATP+KLA
 NM_172739 glucocorticoid receptor DNA binding factor 1 (Grlf1), mRNA [NM_172739] KLA 1.65 1.31 1.14 1.07 .99 1.16 .94
ATP .85 .69 .90 .69 .86 1.87 .87
KLA/ATP 1.26 1.23 1.21 .76 1.23 1.99 1.66
Icam1
KLA  ATP  ATP+KLA
 BC008626 intercellular adhesion molecule, mRNA (cDNA clone MGC:6195 IMAGE:3588949), complete cds [BC008626] KLA 36.67 32.93 28.63 27.91 14.65 8.16 4.15
ATP .96 .88 1.50 3.88 4.98 3.90 1.01
KLA/ATP 32.58 31.60 42.74 32.60 26.00 13.02 6.01
Icam1
KLA  ATP  ATP+KLA
 NM_010493 intercellular adhesion molecule 1 (Icam1), mRNA [NM_010493] KLA 15.66 15.20 12.96 12.31 9.39 6.17 3.81
ATP .96 1.06 1.21 4.19 4.33 3.16 1.06
KLA/ATP 14.31 15.46 17.84 17.60 13.77 8.36 5.42
Itga4
KLA  ATP  ATP+KLA
 NM_010576 integrin alpha 4 (Itga4), mRNA [NM_010576] KLA 4.65 4.83 4.47 3.76 2.93 1.65 1.01
ATP 1.10 1.12 1.17 1.08 .86 .75 .36
KLA/ATP 4.82 5.02 4.43 3.69 2.11 1.13 .79
Itgal
KLA  ATP  ATP+KLA
 AK156251 activated spleen cDNA, RIKEN full-length enriched library, clone:F830013L17 product:integrin alpha L, full insert sequence [AK156251] KLA 5.36 5.78 4.86 5.55 7.02 8.63 11.12
ATP .99 1.17 1.22 1.57 1.35 1.95 3.79
KLA/ATP 5.42 5.89 4.95 5.91 3.96 4.93 10.15
Itgal
KLA  ATP  ATP+KLA
 NM_008400 integrin alpha L (Itgal), mRNA [NM_008400] KLA 4.48 5.17 5.28 5.82 7.82 8.09 16.96
ATP 1.03 1.06 1.24 1.44 1.34 2.02 4.59
KLA/ATP 4.71 5.63 5.49 5.60 3.66 4.65 17.76
Itgam
KLA  ATP  ATP+KLA
 NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72
ATP 1.17 1.19 .97 1.16 .86 .65 1.33
KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08
Itgam
KLA  ATP  ATP+KLA
 NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64
ATP 1.15 1.16 .94 1.20 1.00 .78 1.25
KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16
Itgb1
KLA  ATP  ATP+KLA
 NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88
ATP 1.14 1.30 .92 1.07 1.04 .83 .70
KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62
Itgb1
KLA  ATP  ATP+KLA
 U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98
ATP 1.05 .99 .99 1.03 1.03 .97 .94
KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Itk
KLA  ATP  ATP+KLA
 AK037554 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026F16 product:IL2-inducible T-cell kinase, full insert sequence. [AK037554] KLA .89 .95 .91 .89 .94 .76 .70
ATP 1.07 .97 .98 .88 .69 .59 .70
KLA/ATP .98 .96 .84 .86 .72 .60 .49
Itk
KLA  ATP  ATP+KLA
 NM_010583 IL2-inducible T-cell kinase (Itk), mRNA [NM_010583] KLA 1.10 1.22 1.29 1.17 1.15 1.10 1.18
ATP 1.00 1.01 1.04 .97 1.00 .93 1.00
KLA/ATP 1.28 1.22 1.16 1.06 .95 1.00 1.15
Jam2
KLA  ATP  ATP+KLA
 NM_023844 junction adhesion molecule 2 (Jam2), mRNA [NM_023844] KLA 1.84 2.17 1.88 1.76 1.69 1.51 1.46
ATP .97 .93 1.16 1.13 1.15 1.55 1.21
KLA/ATP 1.77 2.07 1.89 1.54 1.41 1.56 1.52
Jam3
KLA  ATP  ATP+KLA
 AK017692 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730470H08 product:junction cell adhesion molecule 3, full insert sequence. [AK017692] KLA .94 1.00 1.01 1.00 1.02 1.00 .93
ATP .97 .99 1.03 .97 .98 .96 .94
KLA/ATP .94 1.04 .94 .91 .93 .87 1.03
Jam3
KLA  ATP  ATP+KLA
 NM_023277 junction adhesion molecule 3 (Jam3), mRNA [NM_023277] KLA .97 1.02 1.06 1.06 1.01 .98 .74
ATP 1.07 1.00 .98 .96 .89 .88 .67
KLA/ATP 1.13 1.07 1.07 .97 .94 .91 .68
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mllt4
KLA  ATP  ATP+KLA
 NM_010806 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (Mllt4), mRNA [NM_010806] KLA .70 .66 .57 .68 .70 .66 .82
ATP 1.03 1.01 1.05 .96 .76 .91 1.15
KLA/ATP .65 .68 .66 .54 .82 1.14 1.10
Mm.10799
6
KLA  ATP  ATP+KLA
 94407580 Unknown KLA .97 .95 .93 1.00 .95 1.00 1.00
ATP .95 1.03 .96 .92 1.03 .93 1.05
KLA/ATP .99 .91 .97 .92 .90 .90 .92
Mm.15909
3
KLA  ATP  ATP+KLA
 149272242 Unknown KLA 1.01 .97 1.01 1.01 1.05 1.02 .99
ATP 1.04 1.01 .95 1.02 .99 .94 .96
KLA/ATP .96 1.01 1.04 .94 .94 1.05 .98
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.26132
9
KLA  ATP  ATP+KLA
 71037402 Unknown KLA 1.53 1.44 1.59 1.66 1.72 1.88 1.09
ATP 1.08 .98 1.38 1.35 1.28 1.25 1.07
KLA/ATP 1.49 1.53 1.97 1.61 1.54 1.25 1.08
Mm.27604
2
KLA  ATP  ATP+KLA
 18702319 Unknown KLA .81 .72 .70 .70 .54 .54 .67
ATP .90 .95 1.17 1.15 1.35 1.32 1.13
KLA/ATP .70 .78 .89 .83 1.09 1.13 .97
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.41758
KLA  ATP  ATP+KLA
 148747503 Unknown KLA 1.68 1.98 1.80 1.70 1.53 1.43 1.42
ATP 1.05 1.08 1.12 1.06 1.09 1.51 1.15
KLA/ATP 1.74 2.06 1.81 1.45 1.47 1.42 1.55
Mm.42304
0
KLA  ATP  ATP+KLA
 94418669 Unknown KLA 1.04 1.14 1.04 1.04 .98 1.05 1.08
ATP .97 .99 1.27 1.21 1.09 1.01 1.03
KLA/ATP 1.07 1.09 1.08 1.06 1.03 1.02 .95
Mm.42529
6
KLA  ATP  ATP+KLA
 170172552 Unknown KLA 1.51 1.59 1.64 1.57 1.87 1.40 1.91
ATP 1.02 1.04 .77 .91 .52 .49 1.04
KLA/ATP 1.63 1.53 1.11 1.32 .80 .69 1.23
Mm.44463
KLA  ATP  ATP+KLA
 118129851 Unknown KLA 1.01 .98 .97 1.02 .93 1.06 1.05
ATP .97 1.01 1.04 1.06 1.02 1.08 .97
KLA/ATP 1.02 1.06 .95 1.04 1.09 1.14 1.03
Mm.45680
7
KLA  ATP  ATP+KLA
 157951728 Unknown KLA 1.00 1.02 1.05 .97 .99 .96 1.05
ATP 1.13 .98 1.00 1.06 1.02 .94 .98
KLA/ATP 1.11 .96 1.08 1.01 .99 1.01 .98
Mm.46514
KLA  ATP  ATP+KLA
 114326498 Unknown KLA 1.06 .98 1.04 .98 1.00 .99 .99
ATP 1.03 .95 1.00 .93 1.00 1.00 .98
KLA/ATP 1.06 .99 .94 .95 .90 .91 1.02
Mmp2
KLA  ATP  ATP+KLA
 NM_008610 matrix metallopeptidase 2 (Mmp2), mRNA [NM_008610] KLA 1.12 1.24 1.48 1.26 1.44 1.19 1.09
ATP 1.05 1.01 1.07 1.08 .93 1.01 1.14
KLA/ATP 1.23 1.26 1.16 1.15 .95 1.11 1.04
Mmp9
KLA  ATP  ATP+KLA
 NM_013599 matrix metallopeptidase 9 (Mmp9), mRNA [NM_013599] KLA 1.49 1.65 1.43 1.32 1.46 1.33 2.10
ATP 1.03 1.05 1.12 1.36 1.17 2.27 5.92
KLA/ATP 1.51 1.64 1.35 1.78 1.34 1.20 2.96
Msn
KLA  ATP  ATP+KLA
 NM_010833 moesin (Msn), mRNA [NM_010833] KLA 1.50 1.65 1.89 1.55 1.91 1.89 1.87
ATP 1.12 1.47 .86 1.52 1.07 1.00 1.33
KLA/ATP 1.76 2.01 1.10 2.07 .92 1.16 1.66
Myl2
KLA  ATP  ATP+KLA
 NM_010861 myosin, light polypeptide 2, regulatory, cardiac, slow (Myl2), mRNA [NM_010861] KLA .88 .93 .94 .95 .94 .77 .60
ATP .96 1.04 1.14 1.06 1.00 .93 .66
KLA/ATP .91 .85 1.07 1.03 .88 .79 .67
Myl7
KLA  ATP  ATP+KLA
 NM_022879 myosin, light polypeptide 7, regulatory (Myl7), mRNA [NM_022879] KLA .95 1.01 1.02 .97 1.00 1.04 1.01
ATP 1.01 1.02 .96 .98 1.00 .98 1.01
KLA/ATP .98 1.06 1.03 .97 .85 1.01 1.00
Mylc2b
KLA  ATP  ATP+KLA
 NM_023402 myosin light chain, regulatory B (Mylc2b), mRNA [NM_023402] KLA .88 .84 .82 .86 .84 1.03 1.08
ATP .97 1.02 1.12 1.24 .96 .83 1.23
KLA/ATP .84 .83 .87 .97 .86 .91 1.34
Mylc2pl
KLA  ATP  ATP+KLA
 NM_021611 myosin light chain 2, precursor lymphocyte-specific (Mylc2pl), transcript variant 1, mRNA [NM_021611] KLA .99 .97 .93 1.05 1.00 1.03 1.00
ATP .99 1.01 1.03 1.03 .98 .97 1.06
KLA/ATP .97 1.03 .93 1.01 .97 1.05 1.05
Mylpf
KLA  ATP  ATP+KLA
 NM_016754 myosin light chain, phosphorylatable, fast skeletal muscle (Mylpf), mRNA [NM_016754] KLA 1.07 1.12 1.08 1.20 1.17 1.27 1.34
ATP 1.00 .90 .98 1.08 .98 1.22 1.09
KLA/ATP 1.00 1.15 1.14 1.18 1.18 1.04 1.19
Ncf1
KLA  ATP  ATP+KLA
 NM_010876 neutrophil cytosolic factor 1 (Ncf1), mRNA [NM_010876] KLA 1.62 1.71 1.81 1.70 1.99 1.64 2.07
ATP 1.02 1.06 .78 1.02 .64 .56 1.08
KLA/ATP 1.87 1.81 1.22 1.73 1.00 .80 1.49
Ncf2
KLA  ATP  ATP+KLA
 NM_010877 neutrophil cytosolic factor 2 (Ncf2), mRNA [NM_010877] KLA .74 .69 .81 .83 1.07 1.20 .89
ATP 1.21 1.13 .91 1.00 .91 1.82 1.19
KLA/ATP .80 .74 .62 .70 .71 1.26 1.27
Ncf4
KLA  ATP  ATP+KLA
 NM_008677 neutrophil cytosolic factor 4 (Ncf4), mRNA [NM_008677] KLA 1.23 1.30 1.19 1.45 1.88 2.46 2.29
ATP .97 .83 .83 .87 1.25 1.99 3.67
KLA/ATP 1.21 1.11 1.04 1.13 1.48 1.70 2.60
Nox1
KLA  ATP  ATP+KLA
 NM_172203 NADPH oxidase 1 (Nox1), mRNA [NM_172203] KLA 2.18 2.93 3.44 2.51 2.84 1.77 1.10
ATP 1.01 .99 1.13 1.21 1.09 1.00 1.03
KLA/ATP 3.07 3.07 1.88 2.30 1.55 1.60 1.14
Nox3
KLA  ATP  ATP+KLA
 NM_198958 NADPH oxidase 3 (Nox3), mRNA [NM_198958] KLA .98 .99 1.01 1.00 1.01 1.07 1.04
ATP 1.04 .95 .95 .96 1.02 .97 .92
KLA/ATP .99 1.03 .93 .99 .93 .95 .99
Ocln
KLA  ATP  ATP+KLA
 NM_008756 occludin (Ocln), mRNA [NM_008756] KLA 1.02 1.04 1.03 1.03 .99 1.05 1.00
ATP 1.03 .98 1.01 1.07 1.05 1.05 1.04
KLA/ATP 1.09 1.00 1.03 1.05 1.06 1.03 1.01
Pecam1
KLA  ATP  ATP+KLA
 AK031380 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030418F13 product:a disintegrin and metalloprotease domain 28, full insert sequence. [AK031380] KLA .95 1.06 1.09 1.02 1.03 .97 1.01
ATP .98 .96 1.04 1.09 1.01 1.04 .97
KLA/ATP 1.04 1.05 1.00 1.14 1.00 1.03 1.07
Pecam1
KLA  ATP  ATP+KLA
 NM_001032378 platelet/endothelial cell adhesion molecule 1 (Pecam1), transcript variant 2, mRNA [NM_001032378] KLA 1.29 1.31 1.58 1.50 1.94 2.18 1.90
ATP 1.03 1.04 1.05 1.22 1.20 1.11 1.19
KLA/ATP 1.30 1.24 1.28 1.63 1.49 1.62 2.13
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Plcg2
KLA  ATP  ATP+KLA
 NM_172285 phospholipase C, gamma 2 (Plcg2), mRNA [NM_172285] KLA .76 .74 .68 .66 .71 .92 .95
ATP .96 .90 .95 .87 .81 .79 .91
KLA/ATP .76 .71 .69 .62 .72 .78 .68
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Ptk2
KLA  ATP  ATP+KLA
 NM_007982 PTK2 protein tyrosine kinase 2 (Ptk2), mRNA [NM_007982] KLA .99 .99 1.02 1.04 1.09 1.22 1.57
ATP 1.04 1.09 .95 .98 .67 .96 .87
KLA/ATP .99 1.03 .87 .93 .81 1.16 1.04
Ptk2b
KLA  ATP  ATP+KLA
 NM_172498 PTK2 protein tyrosine kinase 2 beta (Ptk2b), mRNA [NM_172498] KLA 1.34 1.39 1.78 1.70 2.36 2.26 1.77
ATP 1.08 1.21 .59 .69 .65 .71 1.17
KLA/ATP 1.41 1.55 1.07 1.33 1.07 1.24 1.80
Ptpn11
KLA  ATP  ATP+KLA
 NM_001109992 protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), transcript variant 2, mRNA [NM_001109992] KLA 1.52 1.71 1.59 1.78 1.62 1.57 1.35
ATP 1.04 .93 .86 .79 1.09 1.95 1.90
KLA/ATP 1.59 1.61 1.45 1.11 1.18 1.82 3.02
Ptpn11
KLA  ATP  ATP+KLA
 NM_011202 protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), transcript variant 1, mRNA [NM_011202] KLA 1.32 1.28 1.17 1.21 1.18 1.06 1.05
ATP .97 .77 .71 .56 .90 1.27 1.04
KLA/ATP 1.22 1.21 1.02 .70 .96 1.06 .94
Pxn
KLA  ATP  ATP+KLA
 AK084243 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230012N01 product:inferred: paxillin beta {Homo sapiens}, full insert sequence. [AK084243] KLA 1.06 .92 1.01 .95 .97 .97 1.02
ATP 1.02 1.02 .97 .90 .98 .94 .89
KLA/ATP .96 .97 .98 .91 1.01 1.00 .94
Pxn
KLA  ATP  ATP+KLA
 NM_133915 paxillin (Pxn), transcript variant beta, mRNA [NM_133915] KLA 1.13 1.13 1.14 1.14 1.49 1.60 1.30
ATP 1.11 1.22 .86 1.04 1.14 1.18 1.35
KLA/ATP 1.41 1.22 .80 .92 1.07 1.54 2.60
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Rac2
KLA  ATP  ATP+KLA
 NM_009008 RAS-related C3 botulinum substrate 2 (Rac2), mRNA [NM_009008] KLA 1.55 1.68 1.86 2.15 3.36 3.59 3.74
ATP 1.13 1.16 .74 .99 .84 .91 1.66
KLA/ATP 1.59 1.71 1.19 1.56 1.21 1.60 3.48
Rap1a
KLA  ATP  ATP+KLA
 AK030897 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830450G12 product:RAS-related protein-1a, full insert sequence [AK030897] KLA .83 .80 .92 1.04 1.06 .91 1.06
ATP 1.04 .92 1.11 1.03 1.05 .73 .72
KLA/ATP .83 .81 .97 .75 1.14 .71 .53
Rap1a
KLA  ATP  ATP+KLA
 NM_145541 RAS-related protein-1a (Rap1a), mRNA [NM_145541] KLA .87 .78 .76 .86 .86 .84 1.01
ATP .91 .95 1.33 1.20 1.27 1.04 .81
KLA/ATP .68 .75 .92 .85 1.13 .90 .74
Rap1b
KLA  ATP  ATP+KLA
 M79314 GTP-binding protein RAP1b mRNA, partial cds. [M79314] KLA 2.61 2.95 2.81 2.76 3.07 2.67 1.88
ATP 1.00 1.10 1.00 1.94 1.94 1.72 1.31
KLA/ATP 2.49 2.45 2.03 4.23 3.03 2.60 1.86
Rap1b
KLA  ATP  ATP+KLA
 NM_024457 RAS related protein 1b (Rap1b), mRNA [NM_024457] KLA 2.21 2.35 2.71 2.51 2.86 2.44 1.54
ATP 1.05 .92 .93 1.14 1.30 1.26 1.07
KLA/ATP 2.23 2.15 1.57 2.53 2.16 1.67 1.38
Rapgef3
KLA  ATP  ATP+KLA
 NM_144850 Rap guanine nucleotide exchange factor (GEF) 3 (Rapgef3), mRNA [NM_144850] KLA .25 .26 .26 .25 .35 .62 .92
ATP .91 .81 .96 .98 3.37 .70 1.85
KLA/ATP .22 .25 .36 .39 3.25 1.14 .67
Rapgef4
KLA  ATP  ATP+KLA
 AK080066 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530056J20 product:unclassifiable, full insert sequence. [AK080066] KLA .99 1.06 .98 1.00 .95 1.02 1.01
ATP .98 1.05 1.02 1.09 .99 1.03 1.01
KLA/ATP .98 .98 .91 1.08 .96 .96 .96
Rapgef4
KLA  ATP  ATP+KLA
 NM_019688 Rap guanine nucleotide exchange factor (GEF) 4 (Rapgef4), mRNA [NM_019688] KLA 1.00 .98 1.00 1.01 1.01 1.02 1.02
ATP .98 .99 .99 1.01 1.00 1.03 1.01
KLA/ATP 1.04 1.07 1.02 1.03 1.01 1.03 .97
Rassf5
KLA  ATP  ATP+KLA
 NM_018750 Ras association (RalGDS/AF-6) domain family member 5 (Rassf5), mRNA [NM_018750] KLA .44 .45 .57 .64 1.03 .77 .64
ATP 1.06 1.34 1.12 2.16 1.77 .35 .64
KLA/ATP .55 .48 .39 .79 .78 .39 .43
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Rhoh
KLA  ATP  ATP+KLA
 NM_001081105 ras homolog gene family, member H (Rhoh), mRNA [NM_001081105] KLA 3.41 3.79 3.09 2.52 1.55 1.40 .66
ATP 1.08 1.01 .83 .82 1.37 1.73 2.31
KLA/ATP 3.80 3.94 4.25 3.23 2.34 4.83 3.55
Rock1
KLA  ATP  ATP+KLA
 NM_009071 Rho-associated coiled-coil containing protein kinase 1 (Rock1), mRNA [NM_009071] KLA 2.40 2.48 2.37 3.07 1.94 1.42 1.21
ATP .95 .92 .87 .70 1.13 1.74 .98
KLA/ATP 2.27 2.35 2.56 1.60 1.65 1.56 1.23
Rock2
KLA  ATP  ATP+KLA
 NM_009072 Rho-associated coiled-coil containing protein kinase 2 (Rock2), mRNA [NM_009072] KLA .99 .92 .83 .87 .73 .74 1.04
ATP 1.07 1.31 1.16 1.02 1.02 1.03 .88
KLA/ATP 1.00 1.07 .93 .85 .69 .63 .81
Sipa1
KLA  ATP  ATP+KLA
 NM_011379 signal-induced proliferation associated gene 1 (Sipa1), mRNA [NM_011379] KLA .34 .34 .35 .41 .75 .97 .89
ATP 1.08 1.13 .89 .97 .54 .64 .94
KLA/ATP .36 .36 .31 .37 .40 .78 1.12
Thy1
KLA  ATP  ATP+KLA
 NM_009382 thymus cell antigen 1, theta (Thy1), mRNA [NM_009382] KLA 1.01 1.01 1.01 1.01 .95 1.00 1.03
ATP 1.02 1.03 .96 1.08 1.02 .99 .95
KLA/ATP .98 1.01 .98 1.00 1.03 .95 1.00
Txk
KLA  ATP  ATP+KLA
 D83202 mRNA, one isoform of PTK-RL18. [D83202] KLA 1.21 1.21 .97 .91 1.17 1.24 1.22
ATP .95 1.07 1.08 .99 .92 1.27 1.54
KLA/ATP 1.08 1.07 1.11 1.09 1.00 1.53 1.79
Txk
KLA  ATP  ATP+KLA
 NM_013698 TXK tyrosine kinase (Txk), transcript variant 2, mRNA [NM_013698] KLA 1.40 1.45 1.33 1.53 1.57 1.88 1.51
ATP .98 .93 1.18 1.26 .94 2.22 2.24
KLA/ATP 1.29 1.32 1.39 1.26 1.22 3.34 4.00
Vasp
KLA  ATP  ATP+KLA
 NM_009499 vasodilator-stimulated phosphoprotein (Vasp), mRNA [NM_009499] KLA 4.52 4.78 4.94 4.54 5.95 5.17 5.17
ATP 1.11 1.31 .93 1.41 1.48 1.45 1.14
KLA/ATP 4.65 5.51 4.13 5.08 2.96 2.18 4.11
Vav1
KLA  ATP  ATP+KLA
 NM_011691 vav 1 oncogene (Vav1), mRNA [NM_011691] KLA .79 .83 .98 1.17 1.97 2.42 2.26
ATP 1.06 1.02 .88 1.01 1.34 .82 1.36
KLA/ATP .88 .85 .73 .78 1.25 1.47 2.17
Vav2
KLA  ATP  ATP+KLA
 BC053060 vav 2 oncogene, mRNA (cDNA clone MGC:62363 IMAGE:5704852), complete cds [BC053060] KLA .73 .58 .55 1.16 .76 1.35 1.75
ATP .99 .89 .79 .82 .67 .85 1.09
KLA/ATP .64 .63 .61 .65 .66 .80 1.23
Vav2
KLA  ATP  ATP+KLA
 NM_009500 vav 2 oncogene (Vav2), mRNA [NM_009500] KLA .98 1.05 .98 .99 1.02 1.36 1.43
ATP 1.07 1.06 .96 1.01 .89 .95 1.08
KLA/ATP 1.04 1.05 .98 1.03 .88 .99 1.13
Vav3
KLA  ATP  ATP+KLA
 NM_020505 vav 3 oncogene (Vav3), transcript variant 1, mRNA [NM_020505] KLA .95 .94 .86 .87 .82 .66 .56
ATP 1.06 1.09 .81 1.05 .80 .75 .85
KLA/ATP 1.00 .84 .62 .85 .74 .56 .74
Vcam1
KLA  ATP  ATP+KLA
 NM_011693 vascular cell adhesion molecule 1 (Vcam1), mRNA [NM_011693] KLA 18.71 22.30 20.87 18.09 13.61 6.09 2.09
ATP 1.08 1.00 1.56 4.23 5.09 5.04 1.50
KLA/ATP 19.09 25.02 26.43 25.42 20.08 11.45 6.67
Vcl
KLA  ATP  ATP+KLA
 NM_009502 vinculin (Vcl), mRNA [NM_009502] KLA .88 .97 .87 .70 .73 .69 .70
ATP 1.07 1.25 1.00 1.24 .87 1.17 1.17
KLA/ATP .98 1.02 .72 .98 .58 .71 .88